Ivana Magovcevic-Liebisch

Ivana Magovcevic-Liebisch

Directeur/Membre du Conseil chez QUANTERIX CORPORATION

Fortune : 27 911 $ au 31/05/2026

57 ans
Health Technology
Consumer Services
Commercial Services

Profil

Ivana Magovcevic-Liebisch is President & Chief Executive Officer at Draig Therapeutics Ltd. since 2025.
Independent Director at Acrivon Therapeutics, Inc. and Quanterix Corp.
since 2024.
Trustee at Beth Israel Deaconess Medical Center, Inc., Suffolk University, Museum of Science, and The Boston Ballet, Inc. Advisor at Atlas Venture Advisors, Inc. Formerly President, Chief Executive Officer & Director at Vigil Neuroscience, Inc. from 2020 to 2025.
Chairman at Absci Corp.
from 2021 to 2023.
Director-Intellectual Property & Patent Counsel at Transkaryotic Therapies, Inc. from 1998 to 2001.
Independent Director at Spyre Therapeutics, Inc. from 2018 to 2023.
Independent Director at Beacon Therapeutics (USA), Inc. from 2014 to 2022.
Director at Alivio Therapeutics, Inc. Senior VP & Head-Global Business Development at Teva Pharmaceutical Industries Ltd. from 2013 to 2017.
Chief Operating Officer & Executive Vice President at Dyax Corp.
from 2012 to 2013.
Chief Business Officer & Executive Vice President at Ipsen SA from 2018 to 2020.
Executive VP, Chief Strategy & Development Officer at Axcella Health, Inc. from 2017 to 2018.
Education includes undergraduate degree from Wheaton College (Illinois) in 1989, doctorate from Harvard Medical School, and graduate degree from Suffolk University Law School in 1999.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
18/05/2026 9 366 ( 0,02% ) 14 986 $ 31/05/2026
15/04/2026 4 224 ( 0,01% ) 12 925 $ 31/05/2026

Postes actifs de Ivana Magovcevic-Liebisch

SociétésPosteDébut
ACRIVON THERAPEUTICS, INC. Directeur/Membre du Conseil 08/02/2024
QUANTERIX CORPORATION Directeur/Membre du Conseil 02/10/2024
Directeur/Membre du Conseil -
Consultant / Advisor -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -

Anciens postes connus de Ivana Magovcevic-Liebisch

SociétésPosteFin
VIGIL NEUROSCIENCE, INC. Directeur Général 05/08/2025
SPYRE THERAPEUTICS, INC. Directeur/Membre du Conseil 22/11/2023
░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Ivana Magovcevic-Liebisch

Formation de Ivana Magovcevic-Liebisch

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

67

Relations au 1er degré

20

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées20

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Consumer Services

Consumer Services

Health Technology

Health Services

Consumer Services

Consumer Services

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Ivana Magovcevic-Liebisch
DERNIÈRES HEURES | -40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT